Advertisement
Research Article

Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments

  • Isabelle Boutron mail,

    To whom correspondence should be addressed. E-mail: isabelle.boutron@bch.ap-hop-paris.fr

    Affiliations: INSERM, U738, Paris, France, Université Paris 7, UFR de Médecine, Paris, France, AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostastique et Recherche Clinique, Paris, France

    X
  • Lydia Guittet,

    Affiliations: INSERM, U738, Paris, France, Université Paris 7, UFR de Médecine, Paris, France, AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostastique et Recherche Clinique, Paris, France

    X
  • Candice Estellat,

    Affiliations: INSERM, U738, Paris, France, Université Paris 7, UFR de Médecine, Paris, France, AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostastique et Recherche Clinique, Paris, France

    X
  • David Moher,

    Affiliations: Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada

    X
  • Asbjørn Hróbjartsson,

    Affiliation: Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark

    X
  • Philippe Ravaud

    Affiliations: INSERM, U738, Paris, France, Université Paris 7, UFR de Médecine, Paris, France, AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostastique et Recherche Clinique, Paris, France

    X
  • Published: February 20, 2007
  • DOI: 10.1371/journal.pmed.0040061

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.